Dr. Tandy Tipps Talks Critical Factors & Strategies for Choosing the Right Site for Oncology Trials
In an interview with KNect365, Precision Oncology’s Dr. Tandy Tipps, VP, Oncology Site Network, tells you how to match the right sites to the right trials and enable the opportunities of precision oncology trials. (more…)
Galante and Hennessey Emphasize Importance of Patient Support Services
In an article in Pharmaceutical Commerce, Precision’s Dominic Galante and Maureen Hennessey stress the importance of patient support services among pharma companies, payers, and providers. (more…)
Read Part 2 of Precision’s Take on the Changing View of Biosimilars
In part 2 of their Guest Commentary series, Precision’s Todd Edgar, Alex Grosvenor, and Kellie Rademacher highlight the takeaways of the NOR-SWITCH trial and how the EU’s view of biosimilars as therapeutic alternatives is influencing US policy. (more…)
Don’t Miss Precision Xtract and MM&M’s Free Live Webinar & Protect Your Innovation From Unfair Value Assessment
Register today for our upcoming free live webinar Defend Your Value: Syncing Evidence and Access Strategies to Prepare for US Value Assessments on Wednesday, April 18, at 1:00 pm ET. (more…)
Maclean and Jansen Advocate for Open-Source Modeling in Pharmaceutical Executive
Precision’s Ross Maclean and Jeroen Jansen encourage biopharma and medical device industries to embrace the developments around value assessment and to take a leading role in improving the transparency of cost-effectiveness evaluations. (more…)